TheProfitWatch

HALO - Halozyme Therapeutics, Inc.

Day 1m 10m 60m PreMarket Market AfterHours Gap
68.55 1.61 (2.34%) 0.0 (0.0%) 0.0 (0.01%) -0.33 (-0.48%) 0.16 (0.23%) 1.19 (1.72%) 0.0 (0.0%) 0.26 (0.38%)

Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors. Halozyme focuses on developing its proprietary products in therapeutic areas with a focus on oncology, and licensing its technology to biopharmaceutical companies to collaboratively develop products. The company's operations are based in the United States, with minimal long-lived assets located internationally.

Category: BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
Market Period: Market

Earnings & Ratios

Basic EPS:
1.36
Diluted EPS:
1.33
Basic P/E:
51.5846
Diluted P/E:
52.7481
RSI(14) 1m:
50.62
VWAP:
70.16
RVol:

Events

Period Kind Movement Occurred At

Related News